progressive supranuclear palsy

E804589

Progressive supranuclear palsy is a rare neurodegenerative movement disorder characterized by early postural instability, vertical gaze palsy, and cognitive and behavioral changes due to widespread tau pathology in the brain.

Jump to: Statements Referenced by

Statements (58)

Predicate Object
instanceOf movement disorder
neurodegenerative disease
tauopathy
affectsAnatomicalStructure basal ganglia
brainstem
frontal cortex NERFINISHED
globus pallidus
substantia nigra NERFINISHED
subthalamic nucleus NERFINISHED
hasAbbreviation PSP
hasCause abnormal tau metabolism
hasCourse progressive
hasDiagnosticTool brain MRI
clinical examination
functional imaging (e.g., PET, SPECT)
hasEpidemiology rare worldwide
hasMedianSurvival approximately 6 to 10 years from symptom onset
hasNoCure true
hasOnset late adulthood
hasPathology 4R tauopathy
gliosis
neurofibrillary tangles
neuronal loss
tau protein aggregation
hasPrognosis poor
hasRiskFactor genetic susceptibility
older age
hasSexPredominance slight male predominance
hasSymptom apathy
axial rigidity
behavioral changes
bradykinesia
cognitive impairment
dysarthria
dysphagia
dystonia
early falls
executive dysfunction
frontal lobe syndrome
gait freezing
neck extension (retrocollis)
postural instability
pseudobulbar affect
sleep disturbances
supranuclear ophthalmoplegia
vertical gaze palsy
hasTreatment occupational therapy
physiotherapy
speech therapy
supportive care
symptomatic pharmacologic therapy
hasTypicalAgeOfOnset 60s
isCharacterizedBy early postural instability
frontal cognitive and behavioral changes
vertical supranuclear gaze palsy
isOftenMisdiagnosedAs Parkinson's disease
atypical parkinsonism
medicalCondition rare disease

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

substantia nigra pathologyAssociatedWith progressive supranuclear palsy